BackPell Bio-Med Technology , Ltd. Overview

Pell Bio-Med Technology , Ltd. Current Assets

Pell Bio-Med Technology , Ltd.'s current assets is $2.3B.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$2.34B
↑ 136.84% YoYΔ $1.35B vs prior year quarter

Peer trimmed avg / median

Loading

Pell Bio-Med Technology , Ltd. Current Assets History

Loading

Pell Bio-Med Technology , Ltd. vs. peers: Current Assets Comparison

Loading

Pell Bio-Med Technology , Ltd. Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Pell Bio-Med Technology , Ltd. (6949.TW) FAQ

The latest current assets for 6949.TW is $2.3B as of June 2026. That compares with $990M in the prior-year period — up 136.8% year over year. Investors often review this figure alongside Pell Bio-Med Technology , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 6949.TW's current assets moved from $990M to $2.3B — a 136.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Pell Bio-Med Technology , Ltd.'s operating scale or balance-sheet position.

A current assets figure of $2.3B for 6949.TW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 6949.TW's current assets ($2.3B), review year-over-year change from $990M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Pell Bio-Med Technology , Ltd.'s current assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.